Shares digital

Gore fund underscores green agro-chemical company’s excellent prospects by Timon Day A fund run by former vice president and environmental campaigner Al Gore increased its stake in Plant Health Care to 5.3% last week and could go substantially... READ MORE >>

Staffing agency floats in the face of worsening employment by Dan Coatsworth Despite millions of pounds having been wiped off the valuation of recruitment companies in the past year, a new staffing agency has floated this week in the hope of using shares to fund acquisitions. Rethink ... READ MORE >>

Business class airline sees talks with potential saviour Kingplace break down by Rachel Robson Friday the thirteenth certainly proved unlucky for the 420 employees of troubled business-class only airline Silverjet, after they were all laid off when a second rescue deal failed to go... READ MORE >>

Numis Securities analyst James Hamilton ladles on the gloom for UK money lenders by Simon Keane First came the liquidity crisis then the asset write downs and now investors in the UK’s lenders have the prospect of rising bad debts to contend with. With a recession the... READ MORE >>

Supply chain software chief executive looks to legislation and booming Asian growth to help business by Russ Mould Shares in supply chain control software expert Kewill Systems lie just below last November’s 101p high. But a prospective PE of barely 9 for 2008 looks to price... READ MORE >>

The crunch hits semiconductors by Russ Mould The credit crunch, rising inventories and the effect of the oil price on consumer spending all appear to have weighed upon the Semiconductor Industry Association's revised growth forecasts for the global chip industry in 2008. The highly... READ MORE >>

Planning consent opens door to £200 million biomass plant by Carlo Svaluto Moreolo Biomass plant developer Helius Energy has been given long-awaited planning consent by energy minister Malcolm Wicks for a £200 million biomass plant in Stallingborough, Lincolnshire. The... READ MORE >>

Risk-averse investors catch biotech companies short by Susanna Twidale Funding pressures and risk-adverse investors are threatening the future of drug development, according to the latest biotechnology report from patent attorney’s Marks & Clark. ‘While the long-term ... READ MORE >>